How to Use Low-Dose Atropine to Slow Myopic Progression in Kids
2016年12月1日 — According to Dr. Siatkowski, low-dose atropine has slowed the rate of myopic progression in his patients by between 30% and 50%. And 2 patients have had complete arrest of their myopic progression. “Both of these are Asian children with dark eyes who were moderate myopes to begin with,” he noted.
Low-Dose Atropine to Slow Myopia: Evidence and Adoption Are Growing
2021年8月1日 — The ATOM1 study found atropine to be superior to placebo, and ATOM2 found that low dosages also slowed the progression of myopia. The LAMP study used a range of low dosages of atropine to see which was most effective.
The Role of Atropine in Preventing Myopia Progression: An Update
Topical 0.01% Atropine for the Control of Fast Progressing Myopia (Myopie-STOP), with the aim of evaluating the efficacy at 1 year of 0.01% atropine on the reduction of fast progressing myopia in children aged 4–12, compared to a placebo .
Efficacy and safety of atropine to control myopia progression: a ...
2020年12月7日 — Song et al. identified that the effectiveness of atropine was related to its dose. A low dose of atropine worsened the progression of myopia. 0.5 and 1.0% of atropine could safely and effectively control the progression of low to moderate myopia [22].
Update in myopia and treatment strategy of atropine use in myopia …
2018年6月11日 — Atropine is currently the most effective therapy for myopia control. Recent clinical trials demonstrated low-dose atropine eye drops such as 0.01% resulted in retardation of...
Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control
Meaning Results do not support the use of atropine, 0.01%, eye drops nightly to slow progression of myopia in US children; future studies of myopia control should test stronger concentrations of atropine or optical and environmental approaches to reduce myopia progression, which may reduce the risk of adult myopic macular degeneration and ...
Atropine Eye Drops for Myopia Control in Childhood—More …
The Atropine Treatment Long-Term Assessment Study (ATLAS) has provided important very-long-term outcome data concerning the effectiveness and safety for prescribing various concentrations of atropine eye drops (0.01%, 0.1%, 0.5%, and 1.0%) for myopia control. 1 The study findings affirm the importance of randomized short-term treatment trials ...
Three-Year Clinical Trial of Low-Concentration Atropine for Myopia ...
2021年8月6日 — Low-Concentration Atropine for Myopia Progression (LAMP) Study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control
Low concentration atropine and myopia: a narrative review of the ...
2023年9月16日 — In this paper we will discuss the use of atropine for myopia management, focussing on mechanisms of action and evidence for its efficacy alongside what we still need to learn about atropine...
Low-dose atropine eyedrops no better than placebo for slowing myopia …
2023年7月13日 — Use of low-dose atropine eyedrops (concentration 0.01%) was no better than placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two years, according to a randomized controlled trial conducted by the Pediatric Eye Disease Investigator Group (PEDIG) and funded by the National Eye Institute ...
- 某些结果已被删除